Target intelligence / Profile preview

Long non-coding RNA ENSG00000279204 (ENSG00000279204)

Target
ENSG00000279204
Molecular classification
Long non-coding RNA (lncRNA), Competing endogenous RNA (ceRNA), Non-protein coding RNA
01

Overview

ENSG00000279204 encodes a long non-coding RNA that acts as a competing endogenous RNA in breast cancer, particularly by interacting with hsa-miR-375 to regulate the tumor suppressor gene SOX17. Increased ENSG00000279204 expression can upregulate SOX17 and is associated with decreased growth and improve outcomes in breast cancer models, highlighting its drug target potential in ceRNA networks of cancer biology[1]. There is still limited clinical evidence and characterization outside computational and preclinical investigations. This lncRNA is primarily annotated by its Ensembl identifier, with no alternative gene symbol or name established in major genomic databases[3]. Notes: - ENSG00000279204 is a non-coding RNA, and as such is not a receptor, enzyme, transporter, or classical protein target. Its function is regulatory within RNA networks. - Its canonical identifier is the Ensembl gene ID, as there is no approved HGNC symbol or standardized functional name[3]. - Literature describes it as a promising experimental target in ceRNA-mediated cancer therapy, specifically for breast cancer[1].

Other names
lncRNA ENSG00000279204
02

Mechanism of action

ceRNA crosstalk: Competes for binding to hsa-miR-375, thereby modulating availability of this miRNA to regulate SOX17 expression, which plays a role in breast tumor growth and prognosis

03

Biological functions

MicroRNA (miRNA) competitionRegulation of SOX17 expressionModulation of breast cancer cell growth through miRNA-mediated mechanisms
04

Disease associations

Cancer (specifically breast cancer; implicated in regulation of tumor suppressor gene expression and potential as a drug target)
05

Safety considerations

Not established; no clinical data regarding safety, off-target or toxicological concerns for targeting this lncRNA
06

Biomarkers

High expression of ENSG00000279204 may serve as an indirect biomarker for SOX17 activity and breast cancer prognosis

Beyond the preview

Go deeper on Long non-coding RNA ENSG00000279204 (ENSG00000279204).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long non-coding RNA ENSG00000279204 (ENSG00000279204).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call